GLP1s and AUD, CVD risk, lipid lowering targets, and status on vaccine for gonorrhea
This week's topics include GLP1s and AUD, impact of CVD risk calculation, meeting lipid lowering targets, and no luck with a vaccine for gonorrhea.
Program notes:
0:38 New guidelines for CVD risk
1:40 21% were reclassified
2:40 More contemporary populations and better data
3:30 Existing meningitis vaccine for gonorrhea
4:30 Incidence in both groups the same
5:30 Randomized trial important
6:18 Prevalence of elevated LDL
7:18 High risk 83% of individuals
8:18 Should be a primary focus
8:30 Taking a GLP1 agonist and AUD
9:30 Did result in fewer hospitalizations for AUD when used
10:30 Relative risk reduction
11:30 Pretty low bar
12:41 End